BridgeMD
Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis - CiGal-EI-TEP
EU CTIS ID: 2024-514331-24-00
What this study is testing
Estimation of sensitivity of PET/CT with Gallium 68 citrate (68GaPET/CT) for the diagnosis of prosthetic valve infective endocarditis in patients suspected of infective endocarditis on prosthetic valve.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult patient (over 18 years old)
- Patient with a prosthetic heart valve
- Patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data)
- Patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis
- Patient beneficiary of a social security scheme
- Free, informed and written consent signed by the participant and the investigator
You likely can't join if
- pregnant or breastfeeding women
- women of childbearing potential not using effective contraception
- patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent)
- Patient with cardiac surgery within 2 months of inclusion
- Subject in a period of relative exclusion due to another protocol
- Known contraindication to PET/CT with injection of radiotracers (hypersensitivity to radiopharmaceuticals and/or excipients)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.